Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-132
Closed -$8.15K 909
2025
Q1
$8.15K Hold
132
﹤0.01% 1027
2024
Q4
$9.52K Buy
132
+11
+9% +$859 ﹤0.01% 995
2024
Q3
$9.38K Sell
121
-5
-4% -$400 ﹤0.01% 1013
2024
Q2
$9.36K Buy
126
+5
+4% +$375 ﹤0.01% 961
2024
Q1
$9.17K Buy
+121
New +$9K ﹤0.01% 963

Other funds holding HOLX

Continuum Advisory's HOLX Position: Q2 2025 in Review

Continuum Advisory sold out of Hologic (HOLX) in Q2 2025, closing a stake of 132 shares — an estimated $8.15K sold.

Continuum Advisory first reported a position in HOLX in Q1 2024 and held it in 5 quarters. The position peaked at $9.52K in Q4 2024. 693 funds tracked by Wall St. Rank hold HOLX as of Q2 2025.

  • Continuum Advisory reported no remaining Hologic position as of Q2 2025 after selling out during the quarter.
  • Continuum Advisory sold 132 Hologic shares in Q2 2025, an estimated $8.15K.
  • Continuum Advisory first reported a position in Hologic in Q1 2024 and held it in 5 quarters.
  • Continuum Advisory's Hologic position peaked at $9.52K in Q4 2024.
  • 693 funds tracked by Wall St. Rank held Hologic as of Q2 2025.

Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.